Group 2 identified four main challenges: lack of national financing and transition plans post-GAVI support; limited community and health worker acceptance; global HPV vaccine supply constraints; and insufficient, poorly adapted communication strategies, especially with social media misinformation. Opportunities include leveraging school health networks, integrating with community associations, mobilizing parliamentary health groups for advocacy, and using existing technical working groups to strengthen stakeholder engagement and resource mobilization